查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1169166

临床前资产市场：按服务分类（生物分析和 DMPK 试验、毒理学试验、化合物管理、模型类型、最终用户、地区）- 规模、份额、前景、机会分析2022-2030

Preclinical Assets Market, by Service ( Bioanalysis and DMPK studies, Toxicology Testing, compound management, by Model type, by End user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3个工作天内

价格
简介目录

临床前资产包括生物分析和 DMPK（药物代谢和药代动力学）研究（加上体外和体内分析、GLP 和非 GLP（良好实验室规范）毒理学研究、化合物管理流程研发（研发）、定制合成、不对称合成和其他（放大、cGMP、安全药理学）等。临床前资产有两类：患者来源的类器官（PDO）模型和患者来源的异种移植模型。是的。

市场动态

主要市场参与者在临床前试验中启动的服务数量不断增加，预计将在预测期内推动全球临床前资产市场的增长。 例如，2020 年 7 月，化妆品公司 Skinobs 宣布新推出临床前测试平台 skinobs，这是一个独立的工具，可提供 360 度全方位的体内功效测试视野。 该平台允许用户根据各种标准识别和选择测试方法，例如：

  • 测试类别：包括分析测试、内容物-空气相互作用、生态毒性和生物降解性测试、安全测试、UV（紫外线）测试等。
  • 声明：包括抗衰老、抗污染等。
  • 测试支持：包括细胞培养、3D 皮肤模型等。

同样，2021 年 12 月，软件公司 Sirona Medical 在 2021 年北美放射学会 (RSNA) 年会上宣布，其云原生放射学技术将优化新型 AI（人工智能）应用程序在临床中的使用。宣布推出学术操作系统（RadOS）。 该平台基于技术和人工智能的结合，将有助于增强医生在临床环境中的智能。

这项研究的主要特点

  • 本报告以 2021 年为基准年，详细分析了 2022 年至 2030 年预测期内的全球临床前资产市场、市场规模（百万美元）和復合年增长率（CAGR（%））分析。
  • 本文阐述了各个细分市场的潜在创收机会，并描述了该市场具有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素和推动因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 根据公司概况、财务业绩、产品组合、地域分布、分销战略、主要发展和战略等参数对全球临床前资产市场的主要参与者进行了概况分析。
  • 本研究涵盖的主要公司包括 Eurofins Scientific、ICON plc、WuXi AppTec、Viroclinics Xplore、Medpace, Inc.、Charles River Laboratories.、Pharmatest Services、PPD Inc.、SGS SA (SGS)、Intertek Group plc、Labcorp Drug Development, Laboratory Corporation of America, Inc.、Crown Bioscience、Comparative Biosciences, Inc.、TCG Lifesciences Private Limited.、Shanghai Medicilon Inc.、Domainex、Absorption Systems、AmplifyBio 和 IQVIA
  • 这份报告中的见解将使企业营销人员和高管能够就未来的产品发布、政府举措、技术升级、市场扩张和营销策略做出明智的决策。这似乎是有可能的。
  • 《全球临床前资产市场》报告面向该行业的各种利益相关者，包括投资者、产品製造商、分销商、供应商、研究和咨询公司、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球临床前资产市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第2章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按服务分类
    • 按型号类型划分的市场概况
    • 市场概况：按最终用户分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要发展状况
  • 技术进步
  • 监管状况
  • 害虫分析

第 4 章全球临床前资产市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 总体影响
  • COVID-19 对市场的影响

第 5 章全球临床前资产市场：按服务分类，2017-2030

  • 2022 年和 2030 年市场份额分析 (%)
  • 2017-2030 年同比增长率分析
  • 生物分析和 DMPK 研究
  • 体外
  • 体内
  • 毒理学测试
  • GLP
  • 非 GLP
  • 复合管理
  • 工艺研发
  • 自定义合成
  • 不对称合成
  • 其他（放大、cGMP）
  • 安全药理学
  • 其他（化学等）

第 6 章全球临床前资产市场：按模型类型分类，2017-2030

  • 患者来源的类器官 (PDO) 模型
  • 患者来源的异种移植模型

第 7 章全球临床前资产市场：按最终用户分类，2017-2030

  • 生物製药公司
  • 政府机构
  • 其他（学术/研究机构）

第 8 章全球临床前资产市场：按地区划分，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第9章竞争格局

  • 热图分析
  • 公司简介
    • Eurofins Scientific
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA（SGS）
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA

第10章 章节

  • 参考文献
  • 调查手法介绍
  • 关于出版社
简介目录
Product Code: CMI5326

Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Laboratory Practices), compound management process R&D (Research and development), custom synthesis, asymmetric synthesis, and others (Scale-up, cGMP (current good manufacturing practices), safety pharmacology. Preclinical assets have two types of models, patient derived organoid (PDO) model and patient derived xenograft model.

Market Dynamics

Increasing number of service launch in preclinical testing by the key market players is expected to drive growth of the global preclinical assets market during the forecast period. For instance, in July 2020, Skinobs, a cosmetic company, announced the launch of a new preclinical testing platform skinobs, an independent tool which provides a 360-degree vision of in vivo efficacy testing. This platform enables users to identify and select the testing methods depending on various criteria such as

  • Test Category: which include analytical tests, content-contenair interaction, ecotoxicity and biodegradability tests, safety tests, UV (Ultra Violet ) tests, etc.
  • Claim: which include anti-ageing, anti-pollution, etc.
  • Test support: which include cell cultures, 3D skin models, etc.

Similarly, in December 2021, Sirona Medical, a software company, announced the launch of its cloud-native radiology operating system (RadOS) optimizing the use of novel AI (Artificial Intelligence) applications in clinical practice at the 2021 Annual Meeting for Radiological Society of North America (RSNA). The platform was based on the combination of technology and artificial intelligence, which would help augment the intelligence of the physician in clinical practices.

Key features of the study:

  • This report provides an in-depth analysis of the global preclinical assets market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global preclinical assets market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Eurofins Scientific, ICON plc, WuXi AppTec, Viroclinics Xplore, Medpace, Inc., Charles River Laboratories., Pharmatest Services, PPD Inc., SGS SA (SGS), Intertek Group plc, Labcorp Drug Development, Laboratory Corporation of America, Inc., Crown Bioscience, Comparative Biosciences, Inc., TCG Lifesciences Private Limited., Shanghai Medicilon Inc., Domainex, Absorption Systems, AmplifyBio, and IQVIA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global preclinical assets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical assets market

Detailed Segmentation:

  • Global Preclinical Assets Market, By Service:
    • Bioanalysis and DMPK studies
      • In vitro
      • In-vivo
    • Toxicology Testing
      • GLP
      • Non-GLP
    • Compound Management
      • Process R&D
      • Custom Synthesis
      • Asymmetric Synthesis
      • Others (Scale-up, cGMP, etc.)
    • Safety Pharmacology
    • Others (Chemistry, etc.)
  • Global Preclinical Assets Market, By Model Type:
    • Patient Derived Organoid (PDO) Model
    • Patient derived xenograft model
  • Global Preclinical Assets Market, By End User:
    • Biopharmaceutical Companies
    • Government Institutes
    • Others (Academic and Research institutes)
  • Global Preclinical Assets Market, By Region:
    • North America
      • By Country
    • US
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Eurofins Scientific*
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA (SGS)
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service
    • Market Snapshot, By Model Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Regulatory Landscape
  • PEST Analysis

4. Global Preclinical Assets Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Preclinical Assets Market, By Service, 2017 - 2030, (US$ Million)

  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017- 2030
    • Segment Trends
  • Bioanalysis and DMPK studies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • In vitro
  • In-vivo
  • Toxicology Testing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • GLP
  • Non-GLP
  • Compound Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Process R&D
  • Custom Synthesis
  • Asymmetric Synthesis
  • Others (Scale-up and cGMP)
  • Safety Pharmacology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Chemistry, etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Preclinical Assets Market, By Model Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Patient Derived Organoid (PDO) Model
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Patient derived xenograft model
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Preclinical Assets Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Government Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Academic and Research institutes)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Preclinical Assets Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • ICON plc
    • WuXi AppTec
    • Viroclinics Xplore
    • Medpace, Inc.
    • Charles River Laboratories.
    • Pharmatest Services
    • PPD Inc.
    • SGS SA (SGS)
    • Intertek Group plc
    • Labcorp Drug Development
    • Laboratory Corporation of America, Inc.
    • Crown Bioscience
    • Comparative Biosciences, Inc.
    • TCG Lifesciences Private Limited.
    • Shanghai Medicilon Inc.
    • Domainex
    • Absorption Systems
    • AmplifyBio
    • IQVIA
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us